Executive Summary: North America Cannabis Testing Market

Market Scope: Comprehensive regional analysis of North America's cannabis testing market, detailing analytical procedures, instrumentation products, end-user settings, and country-level legalization impacts.
Market Valuation: Valued at USD 602.55 million in 2025, reaching USD 681.48 million in 2026, and projected to expand to USD 1824.54 million by 2034, growing at a robust CAGR of 13.1% from 2026 to 2034.
Primary Growth Drivers: Expanding cannabis legalization across US states and Canada, strict regulatory contaminant screening mandates, and rising private and government R&D investments.

Key Market Segment Metrics

Category	Leading Segment (Base Position)	Fastest-Growing / High-Growth Segment
By Testing Procedures	Potency Testing (dominant base position, mandatory for cannabinoid profiling and product labeling)	Pesticide & Residual Solvent Screening (high-growth segment driven by stringent safety regulations)
By Product & Software	Analytical Instruments (major market share holder, anchored by chromatography and mass spectrometry systems)	Software & LIMS (fastest-growing segment, propelled by data automation and laboratory compliance needs)
By End-User	Laboratories & Testing Facilities (primary segment holding the largest share due to mandatory compliance testing)	Cannabis Cultivators (fast-growing segment driven by in-house quality control and pre-harvest screening)
By Country	United States (market leader with the largest share backed by widespread state-level medical and recreational legalization)	Canada (fast-growing federally regulated market expanding through rigorous standardized testing frameworks)

Major Market Players & Industry Landscape

Market Structure: Highly competitive analytical instrument landscape characterized by advanced chromatography technologies, specialized testing laboratories, and stringent regulatory compliance frameworks.

Key Companies: Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., and Millipore Sigma.

North America Cannabis Testing Market Size

The North America cannabis testing market size was valued at USD 602.55 million in 2025 and is estimated to reach USD 1824.54 million by 2034 from USD 681.48 million in 2026, registering a CAGR of 13.1% from 2026 to 2034.

The rising number of cannabis application areas is the key factor driving the expansion of the North American cannabis testing market. The growing demand for cannabis products and the availability of better regulations and laws for medical cannabis uses are further propelling the North American market forward. Increased government and private sector investments in cannabis sector research and development are also expected to boost the market’s growth rate.

The development of safer cannabis products due to the research is expanding the potential for significant companies. Therefore, during the forecast period, public and private organizations increased attention to cannabis product research and development is expected to generate attractive growth possibilities for key industry participants in the North American cannabis testing market.

In Addition, official backing for cannabis testing fuels the market expansion. The use of cannabis as a test measure is becoming more common. Several government agencies are undertaking laboratory investigations on cannabis products to promote the cannabis industry expansion. For plant testing, several regulatory organizations have begun to impose broad restrictions on residual solvents, bug sprays, pollutants, heavy metals, microbes, and mycotoxins. It is also resulted in the establishment of numerous new laboratories, particularly in areas where growth is at its peak.

The significant factors restricting the expansion of the North American cannabis testing market are strict rules for cultivating, production, possession, and distribution. Furthermore, the considerable risk of adverse effects connected with cannabis is expected to impede the market expansion in North America.

REGIONAL ANALYSIS

In 2025, the North American market had the largest share of the global market, and it is expected to grow at a promising CAGR during the forecast period, owing to the favorable regulatory bodies and encouraging laws in the region, also which are expected to provide several growth opportunities for market participants in this region. Furthermore, the growth of E-commerce sales and the evolution of online platforms marketing cannabis goods are likely to give attractive prospects for the leading players in the cannabis testing market in North America.

The United States cannabis testing market is expected to account for the largest share in the North American market during the predicted period due to the factors such as cannabis legalization and rising demand for novel cannabis products. In addition, favorable policies and increasing government and private investments, the Canadian cannabis testing market is expected to grow at a promising CAGR during the forecast period.

During the COVID-19 closure or lockdown, cannabis testing continued in a few states, including California and New York. This was done to conduct cannabis testing for both medicinal and COVID-19 treatment purposes. Furthermore, the efficacy of cannabis extracts requires more large-scale validation, and research plans to conduct additional studies on their innovative high Cannabidiol C. Sativa strains. According to the testing results, the extracts might be used in a mouthwash or throat gargle to prevent COVID-19 infection.

Furthermore, in states where medicinal cannabis is permitted, various insurance companies give coverage for drug prescriptions. As of November 2020, 36 states in the United States had authorized or decriminalized the use of medical marijuana. Similarly, marijuana usage for recreational reasons has been legalized in 16 states around the United States.

KEY MARKET PLAYERS

A few of the prominent companies operating in the North America cannabis testing market profiled in the report are Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, and Accelerated Technology Laboratories, Inc.

MARKET SEGMENTATION

This research report on the North America cannabis testing market has been segmented and sub-segmented into the following categories:

By Testing Procedures

Terpene Profiling
Potency Testing
Residual Solvent Screening
Pesticide Screening
Genetic Testing
Heavy Metal Testing
Microbial Analysis

By End-user

Cannabis Cultivators
Laboratories
Drug Manufacturers & Dispensaries
Research Institutes

By Product & Software

Analytical Instruments
Consumables
Software

By Country

United States
Canada
Rest of North America

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

North America Cannabis Testing Market Report